Subtotal Splenic Embolization is a Safe and Effective Treatment for Isolated Splenic Vascular Tumors Associated With Consumptive Coagulopathy
Eric H. Raabe, Jeffrey R. Keefer, Sally E. Mitchell, Kelvin Hong, Marc DiFazio, John J. Strouse
Abstract
Eric H. Raabe, Jeffrey R. Keefer, Sally E. Mitchell, Kelvin Hong, Marc DiFazio, John J. Strouse
Abstract
Consumptive coagulopathy is a known complication of large vascular tumors. We describe 2 episodes of consumptive coagulopathy in young children, which were secondary to isolated splenic vascular tumors. One child was successfully treated by subtotal embolization of the spleen, whereas the second child required splenectomy after an initial embolization improved--but did not fully control--his consumptive coagulopathy.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Consumptive coagulopathy is a known complication of large vascular tumors. We describe 2 episodes of consumptive coagulopathy in young children, which were secondary to isolated splenic vascular tumors. One child was successfully treated by subtotal embolization of the spleen, whereas the second child required splenectomy after an initial embolization improved--but did not fully control--his consumptive coagulopathy.
Key concepts: Medicine, Coagulopathy, Consumptive Coagulopathy, Embolization, Splenectomy, Spleen, Kasabach–Merritt syndrome, Complication